Jessica L.Nichols

Associate

Atlanta + 1.404.581.8038

Connect:

Share

Jessica Nichols focuses her practice on the representation of health care and life sciences companies.

Jessica has counseled health care clients on regulatory and compliance issues, including licensure, medical records retention, Medicare enrollment, reporting obligations under the Physician Payments Sunshine Act (PPSA), and health information privacy and security compliance under the Health Insurance Portability and Accountability Act (HIPAA). Additionally, she has conducted due diligence reviews and participated in structuring various health care transactions, including management services agreements and other arrangements for the provision of professional or administrative services. On the life sciences side, Jessica has advised clients on a range of topics regulated by the Food and Drug Administration (FDA), including food labeling and nutritional claims, product promotion, and the regulation of personal protective equipment (PPE).

Prior to starting law school, Jessica worked for three years as an operations manager at an industrial supply company.

Experience

  • STERIS to acquire Cantel Medical for $3.6 billionJones Day is advising STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers for $3.6 billion.
  • STERIS acquires Key Surgical for approximately $850 millionJones Day advised STERIS plc (NYSE: STE) in the $850 million acquisition of Key Surgical, a leading global provider of sterile processing, operating room, and endoscopy products, and a portfolio company of Water Street Healthcare Partners, LLC.
  • SOC Telemed merges with Healthcare Merger Corp.Jones Day provided healthcare and general corporate counsel to SOC Telemed, Inc. in its $720 million merger with Healthcare Merger Corp.
  • Portobello Capital portfolio company acquires BDS Natural ProductsJones Day advised Portobello Capital Gestion SA SGEIC in connection with the acquisition by portfolio company Sabater Spices of BDS Natural Products, a California based producer of botanical and spice ingredients in the North American market, and a key supplier to the food, nutraceutical, and tea industries.
  • Leading specialty telemedicine organization launches novel telemedicine-oriented revenue cycle management offeringJones Day provided health regulatory counsel to one of the Nation’s leading specialty telemedicine organizations for its innovative reimbursement, enrollment, contracting, compliance policies, data privacy, and billing arrangements regarding specialty telemedicine services across the U.S.
    • View All

    January 2021 Newsletters

    Vital Signs Digital Health Law Update Winter 2021

    January 2021 Commentaries

    CMS Finalizes and Clarifies Key Valuation Terms in the Stark Law

    October 2020 Newsletters

    Vital Signs: Digital Health Law Update | Fall 2020

    Additional Publications

    • April 2020
      Vital Signs: Digital Health Law Update | Spring 2020
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.